Literature DB >> 34852931

Coronary Artery Disease Without Standard Cardiovascular Risk Factors.

Ko Yamamoto1, Masahiro Natsuaki2, Takeshi Morimoto3, Hiroki Shiomi1, Yasuaki Takeji1, Kyohei Yamaji4, Yukiko Matsumura-Nakano1, Yusuke Yoshikawa1, Erika Yamamoto1, Masayuki Fuki1, Eri Kato1, Yugo Yamashita1, Hidenori Yaku5, Kenji Nakatsuma5, Hiroki Watanabe6, Mitsuo Matsuda7, Toshihiro Tamura8, Moriaki Inoko9, Hiroshi Mabuchi10, Manabu Shirotani11, Hiroshi Eizawa12, Katsuhisa Ishii13, Tsukasa Inada14, Tomoya Onodera15, Eiji Shinoda16, Takashi Yamamoto17, Mamoru Toyofuku6, Mamoru Takahashi18, Hiroki Sakamoto19, Shinji Miki5, Takeshi Aoyama20, Satoru Suwa21, Yukihito Sato22, Yutaka Furukawa23, Kenji Ando4, Kazushige Kadota24, Yoshihisa Nakagawa17, Takeshi Kimura25.   

Abstract

Recently, one observational study showed that patients with ST-segment elevation myocardial infarction (STEMI) without standard cardiovascular risk factors were associated with increased mortality compared with patients with risk factors. This unexpected result should be evaluated in other populations including those with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and chronic coronary syndrome (CCS). Among 30,098 consecutive patients undergoing first coronary revascularization in the CREDO-Kyoto PCI/CABG (Coronary Revascularization Demonstrating Outcome Study in Kyoto Percutaneous Coronary Intervention/Coronary Artery Bypass Grafting) registry cohort-2 and 3, we compared clinical characteristics and outcomes between patients with and without risk factors stratified by their presentation (STEMI n = 8,312, NSTE-ACS n = 3,386, and CCS n = 18,400). Patients with risk factors were defined as having at least one of the following risk factors: hypertension, dyslipidemia, diabetes, and current smoking. The proportion of patients without risk factors was low (STEMI: 369 patients [4.4%], NSTE-ACS: 110 patients [3.2%], and CCS: 462 patients [2.5%]). Patients without risk factors compared with those with risk factors more often had advanced age, low body weight, and malignancy and less often had history of atherosclerotic disease and prescription of optimal medical therapy. In patients with STEMI, patients without risk factors compared with those with risk factors were more often women and more often had atrial fibrillation, long door-to-balloon time, and severe hemodynamic compromise. During a median of 5.6 years follow-up, patients without risk factors compared with those with risk factors had higher crude incidence of all-cause death. After adjusting confounders, the mortality risk was significant in patients with CCS (hazard ratio [HR] 1.22, 95% confidence interval [CI] 1.01 to 1.49, p = 0.04) but not in patients with STEMI (HR 1.06, 95% CI 0.89 to 1.27, p = 0.52) and NSTE-ACS (HR 1.07, 95% CI, 0.74 to 1.54, p = 0.73). In conclusion, among patients undergoing coronary revascularization, patients without standard cardiovascular risk factors had higher crude incidence of all-cause death compared with those with at least one risk factor. After adjusting confounders, the mortality risk was significant in patients with CCS but not in patients with STEMI and NSTE-ACS.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34852931     DOI: 10.1016/j.amjcard.2021.10.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry.

Authors:  Sidong Li; Xiaojin Gao; Jingang Yang; Haiyan Xu; Yang Wang; Yanyan Zhao; Lu Yin; Chao Wu; Yi Wang; Yang Zheng; Bao Li; Xuan Zhang; Yunqing Ye; Rui Fu; Qiuting Dong; Hui Sun; Xinxin Yan; Yuan Wu; Jun Zhang; Chen Jin; Wei Li; Yuejin Yang
Journal:  BMC Med       Date:  2022-07-06       Impact factor: 11.150

2.  Prognostic performance of multiple biomarkers in patients with acute coronary syndrome without standard cardiovascular risk factors.

Authors:  Le Wang; Hong-Liang Cong; Jing-Xia Zhang; Xi-Ming Li; Yue-Cheng Hu; Chen Wang; Jia-Chun Lang; Bing-Yang Zhou; Ting-Ting Li; Chun-Wei Liu; Hua Yang; Li-Bin Ren; Wei Qi; Wen-Yu Li
Journal:  Front Cardiovasc Med       Date:  2022-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.